ArticleOncotarget2017
Treatment of hepatocellular carcinoma with a GPC3-targeted bispecific T cell engager.
Yanyu Bi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this papercites it
ArticleOncotarget2017
Yanyu Bi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.